During the past decade, California Allergy and Asthma Medical Group conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Allergy and Asthma Medical Group" #1 sponsor was "California Allergy and Asthma Medical Group, Inc." with 4 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Novartis" with 2 trials sponsored and "Novartis Pharmaceuticals" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Allergy and Asthma Medical Group" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "McNeil Consumer Healthcare Division of McNEIL-PPC, Inc." with 1 trials as a collaborator and "Tanox" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "California Allergy and Asthma Medical Group" are "Asthma" (9 trials), "Allergic Rhinitis" (2 trials), "Atopic Dermatitis" (2 trials), "COPD" (2 trials) and "Perennial Allergic Rhinitis" (2 trials). Many other conditions were trialed in "California Allergy and Asthma Medical Group" in a lesser frequency.

Most popular intervention types in "California Allergy and Asthma Medical Group" are "Drug" (20 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Lebrikizumab" (2 trials), "Activation Energy Serum" (1 trials), "Activation Mist" (1 trials) and "Albuterol" (1 trials). Other intervention names were less common.

The vast majority of trials in "California Allergy and Asthma Medical Group" are 26 trials for "All" genders.

Currently, there are NaN active trials in "California Allergy and Asthma Medical Group". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in California Allergy and Asthma Medical Group, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in California Allergy and Asthma Medical Group, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".